Posts

Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits

Signal: Kroger to pay up to $1.4bn to settle opioid cri...

Sep 11, 2023

Kroger's settlement, alongside the review of the Purdue Pharma bankruptcy case, ...

Coherus acquires immuno-oncology company Surface

Coherus acquires immuno-oncology company Surface

Sep 11, 2023

Coherus BioSciences has concluded the acquisition of immuno-oncology (I-O) compa...

Grit Biotechnology secures funds for development of pipeline programmes

Grit Biotechnology secures funds for development of pip...

Sep 11, 2023

Grit Biotechnology has secured more than $60m in a Series B funding round to sup...

Biosyngen receives FDA approval to start Phase I trial for TCR therapy

Biosyngen receives FDA approval to start Phase I trial ...

Sep 11, 2023

The US FDA has awarded Biosyngen’s IND for the T-cell receptor therapy, BRL03, t...

Six-year follow-up data on CheckMate 227 survival and quality of life benefits unveiled for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

Six-year follow-up data on CheckMate 227 survival and q...

Sep 10, 2023

[Singapore — 10:35 a.m. SGT–September 10, 2023) — The International Association ...

Amid another rise in cases, Covid’s new normal has set in

Amid another rise in cases, Covid’s new normal has set in

Sep 10, 2023

While the angst over another rise in Covid cases is understandable, there’s some...

STAT+: Crinetics acromegaly drug succeeds in late-stage trial but would face stiff competition if approved

STAT+: Crinetics acromegaly drug succeeds in late-stage...

Sep 10, 2023

Crinetics Pharmaceuticals announced its experimental drug for acromegaly succeed...

Stigmatization of smoking-related diseases is a barrier to care and the problem may be on the rise

Stigmatization of smoking-related diseases is a barrier...

Sep 10, 2023

[Singapore — 10:35 a.m. SGT–September 10, 2023) –The stigma that patients face w...

KRYSTAL-1 trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

KRYSTAL-1 trial finds that adagrasib demonstrates durab...

Sep 10, 2023

[Singapore — 10:35 a.m. SGT–September 10, 2023] — The oral, selective KRAS G12C ...

Benmelstobart plus anlotinib and chemotherapy shows benefit for patients with extensive-stage small-cell lung cancer

Benmelstobart plus anlotinib and chemotherapy shows ben...

Sep 10, 2023

[Singapore — 10:35 a.m. SGT–September 10, 2023] – The combination of benmelstoba...

FLAURA2 results demonstrate osimertinib plus chemotherapy superior compared to osimertinib alone

FLAURA2 results demonstrate osimertinib plus chemothera...

Sep 10, 2023

(Singapore – 10:05 a.m. SGT–September 11, 2023) – Osimertinib plus chemotherapy ...

City living raises the risk of respiratory infections in babies and young children

City living raises the risk of respiratory infections i...

Sep 10, 2023

Milan, Italy: Young children growing up in towns and cities suffer from more res...

Exhaled breath analysis shows promise in detecting malignant pleural mesothelioma

Exhaled breath analysis shows promise in detecting mali...

Sep 10, 2023

[Singapore — 10:35 a.m. SGT–September 10, 2023] — Identifying and analyzing vola...

MARS trial: decortication and chemotherapy associated with worse outcomes for patients with resectable mesothelioma

MARS trial: decortication and chemotherapy associated w...

Sep 10, 2023

(Singapore, September 11, 2023, 10:05 a.m. SGT) – Extended pleurectomy decortica...

Large-scale investigation supports modified classification system for pulmonary adenocarcinomas

Large-scale investigation supports modified classificat...

Sep 10, 2023

(Singapore – 10:05 a.m. SGT–September 11, 2023) – A modified adenocarcinoma clas...

Taiwan launches National Lung Cancer Early Detection Program detects 85 percent of lung cancer cases at early phase

Taiwan launches National Lung Cancer Early Detection Pr...

Sep 10, 2023

First-ever National Screening Program to Consider Family History Credit: Pan-Chy...